|
Bednar, Erica M; Walsh Jr, Michael T; Baker, Ellen et al. (2018) Creation and Implementation of an Environmental Scan to Assess Cancer Genetics Services at Three Oncology Care Settings. J Genet Couns :
|
|
Brown, Paul D; Ahluwalia, Manmeet S; Khan, Osaama H et al. (2018) Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution? J Clin Oncol 36:483-491
|
|
Deshpande, Aditya; Lang, Wenhua; McDowell, Tina et al. (2018) Strategies for identification of somatic variants using the Ion Torrent deep targeted sequencing platform. BMC Bioinformatics 19:5
|
|
Ragon, Brittany Knick; Mehta, Rohtesh S; Gulbis, Alison M et al. (2018) Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit. Bone Marrow Transplant 53:315-325
|
|
Wang, Yumeng; Liang, Han (2018) When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference. Bioessays 40:
|
|
Andrews, Miles C; Reuben, Alexandre; Gopalakrishnan, Vancheswaran et al. (2018) Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy. Front Immunol 9:946
|
|
Jardim, Denis L; de Melo Gagliato, Débora; Giles, Francis J et al. (2018) Analysis of Drug Development Paradigms for Immune Checkpoint Inhibitors. Clin Cancer Res 24:1785-1794
|
|
Abaza, Yasmin; M Kantarjian, Hagop; Faderl, Stefan et al. (2018) Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma. Am J Hematol 93:91-99
|
|
Ok, Chi Young; Loghavi, Sanam; Sui, Dawen et al. (2018) Persistent IDH1/2 mutation in remission can predict relapse in patients with acute myeloid leukemia. Haematologica :
|
|
Ajani, Jaffer A; Estrella, Jeannelyn S; Chen, Qiongrong et al. (2018) Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors. Br J Cancer 118:52-61
|
Showing the most recent 10 out of 12418 publications
